INNOPHARMAX INC

INNOPHARMAX INC. Company Introduction

**Company Name:** INNOPHARMAX INC. (杏國新藥股份有限公司)

**Location:** Taiwan

**Business Type:** Manufacturer / Developer

**Company Overview:**

INNOPHARMAX INC. is a pharmaceutical company based in Taiwan, primarily engaged in the research, development, manufacturing, and commercialization of innovative new drugs. The company focuses on developing novel treatments, particularly in therapeutic areas such as oncology (cancer) and ophthalmology (eye diseases). INNOPHARMAX INC. is a drug developer and manufacturer, not a trading company. They are dedicated to bringing advanced pharmaceutical solutions to the market through their own R&D efforts and production capabilities.

INNOPHARMAX INC PRODUCT LIST

Product Name: Nano-AS

Indication: An oral formulation of Azacitidine used for the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

Product Name: Gemoral

Indication: An oral formulation of Gemcitabine used for the treatment of various solid tumors.

Product Name: Ora-Bortezomib

Indication: An oral formulation of Bortezomib used for the treatment of multiple myeloma and mantle cell lymphoma.

Product Name: Ora-Docetaxel

Indication: An oral formulation of Docetaxel used for the treatment of various cancers, including breast, lung, and prostate cancer.

Product Name: Ora-Paclitaxel

Indication: An oral formulation of Paclitaxel used for the treatment of breast, ovarian, and lung cancers.

Product Name: Ora-Topotecan

Indication: An oral formulation of Topotecan used for the treatment of ovarian and small cell lung cancer.